glp-1 and metabolism receptor agonists next-generation metabolic hormone therapies in chronic kidney disease Biological Role of GLP-1 -

Hormonal therapies might be required where endocrine imbalance underlies infertility, and peptides can be timed to augment those interventions

[,] Some GLP-1, such as liraglutide and exenatide, have shown potential outcomes in non-pregnant populations for improving blood glucose levels and promoting weight loss, making them a potentially appealing option for GDM

8): (1) Insulin-sensitizing synergy: Cinnamaldehyde and curcumin are insulin-sensitizing phytonutrients

Food and Drug Administration (FDA) approved the first oral formulation of semaglutide specifically for chronic weight management in adults

As of July 1, it removed Zepbound from its formulary, which required most patients to switch to Wegovy, regardless of which drug works better for them

10.1016/j.nut.2021.111282 23 Cervantes-BarraganL.ChaiJ